steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 20:04 (399 d 17:30 ago) – Posting: # 20636
Views: 3,389

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?

Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

 Admin contact
21,179 posts in 4,414 threads, 1,474 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Saturday 13:35 CEST (Europe/Vienna)

It is the peculiar and perpetual error of the human understanding
to be more moved and excited by affirmatives than negatives.    Francis Bacon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz